Table 2 Clinicopathological features of the patients in the present study (2019–2021, Number = 30)
Clinicopathological Characteristics of CRC Patients | |
 Male/Female (n (%)) | 20 (66.7%)/10 (33.3%) |
 Age: Mean ± SE | 57 (57 ± 11.04) |
Site of primary | |
 Cecum | 10% |
 Ascending colon | 6.7% |
 Hepatic flexure | 3.3% |
 Transverse Colon | 6.7% |
 Splenic Flexure | 3.3% |
 Descending Colon | 3.3% |
 Sigmoid Colon | 6.7% |
 Rectosigmoid | 6.7% |
 Rectum | 40% |
 Colon, NOS | 13.3% |
Tumor size | |
 Size ≤5 | 53.3% |
 Size > 5 | 46.7% |
Grade | |
 I: (Well Differentiated) | 13.3% |
 II: Moderately Differentiated | 73.3% |
 III: Poorly Differentiated | 6.7% |
 IV: Undifferentiated | 3.3% |
 X: Unknown | 3.3% |
Invasion, Nodal status, and Tumor deposit | |
 Lymphatic | 90% |
 Perineural | 60% |
 Perineal | 6.7% |
 Extramural Blood Vessel | 20% |
 Extra-Nodal Extension | 6.7% |
 Perforation | 3.3% |
 Peritoneal Seeding | 3.3% |
TNM staging | |
 Stage I | 6.7% |
 Stage IIA | 50% |
 Stage IIIB | 16.7% |
 Stage IIIC | 13.3% |
 Stage IV | 13.3% |